Trial Outcomes & Findings for Assessing Neuroinflammation in GWI Using MRS (NCT NCT04638998)

NCT ID: NCT04638998

Last Updated: 2025-01-13

Results Overview

The concentration of myoinositol will be measured in the brain using MRI as a measure of neuroinflammation. This will be measured in both the control and experimental groups.

Recruitment status

COMPLETED

Target enrollment

49 participants

Primary outcome timeframe

20 minutes

Results posted on

2025-01-13

Participant Flow

Participant milestones

Participant milestones
Measure
Healthy Control
The healthy control group are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. This cohort do not experience any Gulf War Illness symptoms. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Gulf War Illness
The GWI cohort are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. The men in this cohort will also meet the Kansas Inclusion Criteria for GWI. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Overall Study
STARTED
21
28
Overall Study
COMPLETED
20
25
Overall Study
NOT COMPLETED
1
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Healthy Control
The healthy control group are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. This cohort do not experience any Gulf War Illness symptoms. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Gulf War Illness
The GWI cohort are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. The men in this cohort will also meet the Kansas Inclusion Criteria for GWI. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Overall Study
Withdrawal by Subject
1
3

Baseline Characteristics

Assessing Neuroinflammation in GWI Using MRS

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Healthy Control
n=21 Participants
The healthy control group are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. This cohort do not experience any Gulf War Illness symptoms. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Gulf War Illness
n=28 Participants
The GWI cohort are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. The men in this cohort will also meet the Kansas Inclusion Criteria for GWI. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Total
n=49 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
21 Participants
n=5 Participants
28 Participants
n=7 Participants
49 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Male
21 Participants
n=5 Participants
28 Participants
n=7 Participants
49 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
White
19 Participants
n=5 Participants
23 Participants
n=7 Participants
42 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
21 participants
n=5 Participants
28 participants
n=7 Participants
49 participants
n=5 Participants

PRIMARY outcome

Timeframe: 20 minutes

Population: Some participants data were excluded due to poor quality

The concentration of myoinositol will be measured in the brain using MRI as a measure of neuroinflammation. This will be measured in both the control and experimental groups.

Outcome measures

Outcome measures
Measure
Healthy Control
n=19 Participants
The healthy control group are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. This cohort do not experience any Gulf War Illness symptoms. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Gulf War Illness
n=20 Participants
The GWI cohort are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. The men in this cohort will also meet the Kansas Inclusion Criteria for GWI. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Concentration of Myoinositol in the Brain
0.001260 Institutional Units (IU)
Standard Deviation 0.0002362
0.001205 Institutional Units (IU)
Standard Deviation 0.0001699

PRIMARY outcome

Timeframe: 20 minutes

Population: Some participants data were excluded due to poor quality

The concentration of lactate will be measured in the brain using MRI as a measure of neuroinflammation. The concentration will be expressed in water-normed "Institutional Units". This will be measured in both the control and experimental groups. Values are expressed as metabolites averaged across the cortical lobes and cerebellum.

Outcome measures

Outcome measures
Measure
Healthy Control
n=19 Participants
The healthy control group are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. This cohort do not experience any Gulf War Illness symptoms. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Gulf War Illness
n=20 Participants
The GWI cohort are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. The men in this cohort will also meet the Kansas Inclusion Criteria for GWI. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Concentration of Lactate in the Brain
0.0003886 Institutional Units (IU)
Standard Deviation 0.0001629
0.0005388 Institutional Units (IU)
Standard Deviation 0.000365

PRIMARY outcome

Timeframe: 20 minutes

Population: Some participants data were excluded due to poor quality

The concentration of choline will be measured in the brain using MRI as a measure of neuroinflammation. This will be measured in both the control and experimental groups.

Outcome measures

Outcome measures
Measure
Healthy Control
n=19 Participants
The healthy control group are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. This cohort do not experience any Gulf War Illness symptoms. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Gulf War Illness
n=20 Participants
The GWI cohort are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. The men in this cohort will also meet the Kansas Inclusion Criteria for GWI. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Concentration of Choline in the Brain
0.0003838 Institutional Units (IU)
Standard Deviation 0.000051446
0.0003499 Institutional Units (IU)
Standard Deviation 0.000034982

PRIMARY outcome

Timeframe: 20 minutes

Population: Some participants data were excluded due to poor quality

The concentration of N-acetylaspartate will be measured in the brain using MRI as a measure of neuroinflammation. This will be measured in both the control and experimental groups.

Outcome measures

Outcome measures
Measure
Healthy Control
n=19 Participants
The healthy control group are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. This cohort do not experience any Gulf War Illness symptoms. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Gulf War Illness
n=20 Participants
The GWI cohort are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. The men in this cohort will also meet the Kansas Inclusion Criteria for GWI. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Concentration of N-acetylaspartate in the Brain
0.0023191 Institutional Units (IU)
Standard Deviation 0.0001821
0.0022186 Institutional Units (IU)
Standard Deviation 0.0001721

PRIMARY outcome

Timeframe: 20 minutes

The temperature of the brain will be measured using MRI as a measure of neuroinflammation. This will be measured in both the control and experimental groups. An amplitude-weighted combination of NAA, creatine, and choline was used as the reference for temperature deviations.

Outcome measures

Outcome measures
Measure
Healthy Control
n=19 Participants
The healthy control group are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. This cohort do not experience any Gulf War Illness symptoms. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Gulf War Illness
n=20 Participants
The GWI cohort are men ages 46-70 who were present in the Persian Gulf War between 1990 and August 1991. The men in this cohort will also meet the Kansas Inclusion Criteria for GWI. Magnetic Resonance Spectroscopic Imaging: MRSI is a non invasive imaging technique used to detect neuroinflammation. Blood draw: Blood will be drawn to assess systemic inflammation in Gulf War verterans.
Temperature in the Brain
36.622 degrees Celsius
Standard Deviation 0.322
36.826 degrees Celsius
Standard Deviation 0.331

Adverse Events

Healthy Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Gulf War Illness

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Jarred Younger

University of Alabama at Birmingham

Phone: 205-975-5821

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place